• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与法国 COVID-19 大流行期间推迟或未能执行有组织的乳腺癌筛查计划相关的因素。

Factors associated with deferral or non-performance of an organized breast cancer screening program during the COVID-19 pandemic in France.

机构信息

Department of General Medicine, Université de Reims Champagne-Ardenne, Reims, Marne, France.

Médecine générale, Maison de Santé Pluriprofessionnelle de la Forêt d'Orient, Piney, Aube, France.

出版信息

Cancer Med. 2024 Aug;13(16):e7444. doi: 10.1002/cam4.7444.

DOI:10.1002/cam4.7444
PMID:39192606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11349821/
Abstract

BACKGROUND

Delays in detection and treatment of breast cancer can lead to increased mortality. To date, participation in organized breast cancer screenings (OBCS) has been suboptimal worldwide. The objective of this study was to investigate the factors associated with deferral or non-performance of mammography during the COVID-19 pandemic for women who had previously participated in OBCS.

METHODS

A retrospective observational study was conducted on a cohort of 6282 women from the Aube Department of France, who were invited to an OBCS in 2020. Participants were divided into women who promptly underwent screening after receiving an invitation (between 22 and 25 months elapsed since the last mammogram), women who underwent late screening (≥26 months since the last mammogram), and those who were never screened. Data were collected from a self-reported questionnaire. Comparative and multivariable analyses modeling the probability of each type of attendance were performed using these data.

RESULTS

In total, 2301 women (aged 50-74 years) returned a valid questionnaire. Compared to women who promptly underwent mammography, non- and late-screening participants were younger, had less frequent gynecological follow-up and a less frequent history of colorectal cancer screening. Women with higher education status and those residing in socially disadvantaged areas were more likely to attend late.

CONCLUSION

The absence of regular gynecological follow-up and the absence of colorectal cancer screening were significant factors associated with deferral of or non-attendance at OBCS.

摘要

背景

乳腺癌的检测和治疗延迟会导致死亡率增加。迄今为止,全球范围内参与有组织的乳腺癌筛查(OBCS)的人数仍不理想。本研究的目的是调查在 COVID-19 大流行期间,先前参与 OBCS 的女性推迟或不进行乳房 X 光检查的相关因素。

方法

对法国奥布省的 6282 名女性进行了一项回顾性观察性研究,这些女性在 2020 年被邀请参加 OBCS。参与者分为三类:及时接受筛查的女性(在最后一次乳房 X 光检查后 22-25 个月内)、延迟接受筛查的女性(最后一次乳房 X 光检查后≥26 个月)和从未接受筛查的女性。数据来自一份自我报告的调查问卷。使用这些数据进行比较和多变量分析模型,以评估每种类型的参与率。

结果

共有 2301 名(年龄在 50-74 岁之间)女性返回了有效的问卷。与及时接受乳房 X 光检查的女性相比,未进行和延迟进行筛查的女性年龄较小,妇科随访较少,结直肠癌筛查较少。受教育程度较高和居住在社会劣势地区的女性更有可能延迟筛查。

结论

缺乏定期的妇科随访和缺乏结直肠癌筛查是导致 OBCS 推迟或不参加的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c979/11349821/75e45d25e28b/CAM4-13-e7444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c979/11349821/75e45d25e28b/CAM4-13-e7444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c979/11349821/75e45d25e28b/CAM4-13-e7444-g001.jpg

相似文献

1
Factors associated with deferral or non-performance of an organized breast cancer screening program during the COVID-19 pandemic in France.与法国 COVID-19 大流行期间推迟或未能执行有组织的乳腺癌筛查计划相关的因素。
Cancer Med. 2024 Aug;13(16):e7444. doi: 10.1002/cam4.7444.
2
Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.乳腺 X 光检查的参与是否会影响宫颈癌和结直肠癌的筛查参与率?一项针对 1856 名法国女性的前瞻性研究。
PLoS One. 2018 Jun 21;13(6):e0198939. doi: 10.1371/journal.pone.0198939. eCollection 2018.
3
Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.法国采用组织性或机会性乳腺癌筛查的女性特征。对2006年法国健康、医疗保健与保险调查的分析。
Rev Epidemiol Sante Publique. 2012 Dec;60(6):421-30. doi: 10.1016/j.respe.2012.05.006. Epub 2012 Nov 10.
4
The effect of organized breast cancer screening on mammography use: Evidence from France.法国的证据表明,有组织的乳腺癌筛查对乳房 X 光检查的使用有影响。
Health Econ. 2018 Dec;27(12):1963-1980. doi: 10.1002/hec.3813. Epub 2018 Aug 6.
5
Study of socio-economic characteristics, diagnosis and outcome of women participating or not participating in mammogram screening.参与或未参与乳房X光筛查的女性的社会经济特征、诊断及结果研究。
Ann Ig. 2014 Nov-Dec;26(6):518-26. doi: 10.7416/ai.2014.2010.
6
Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.美国 COVID-19 大流行期间的乳腺癌筛查:来自真实世界健康记录数据的结果。
Ann Fam Med. 2024 May-Jun;22(3):208-214. doi: 10.1370/afm.3098.
7
Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.乳腺癌筛查项目:挑战与机会性乳腺钼靶检查并存的现状。
Patient Educ Couns. 2014 Dec;97(3):410-7. doi: 10.1016/j.pec.2014.08.016. Epub 2014 Sep 18.
8
Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.妇女健康倡议试验中筛查检出乳腺癌与间期乳腺癌患者的死亡率比较。
JAMA Netw Open. 2020 Jun 1;3(6):e207227. doi: 10.1001/jamanetworkopen.2020.7227.
9
[Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].[意大利北部伦巴第大区大流行前时期(2018 - 2019年)结直肠癌和乳腺癌有组织筛查不依从的预测因素分析]
Epidemiol Prev. 2024 Mar-Apr;48(2):118-129. doi: 10.19191/EP24.2.A720.039.
10
Determination of thresholds of risk in women at average risk of breast cancer to personalize the organized screening program.确定平均乳腺癌风险女性的风险阈值,以实现有组织的筛查计划的个体化。
Sci Rep. 2021 Sep 27;11(1):19104. doi: 10.1038/s41598-021-98604-6.

本文引用的文献

1
Factors influencing participation in breast cancer screening in an urban setting. A study of organized and individual opportunistic screening among potentially active and retired women in the city of Nice.城市环境中影响乳腺癌筛查参与率的因素。对法国尼斯市潜在在职和退休女性中组织性筛查及个体机会性筛查的一项研究。
Prev Med Rep. 2022 Dec 6;31:102085. doi: 10.1016/j.pmedr.2022.102085. eCollection 2023 Feb.
2
Participation rate in cervical cancer screening in general practice related to the proximity of gynecology care facilities: A 3 year follow-up cohort study.初级保健中宫颈癌筛查的参与率与妇科保健设施的接近程度有关:一项为期 3 年的随访队列研究。
Front Public Health. 2022 Oct 17;10:955559. doi: 10.3389/fpubh.2022.955559. eCollection 2022.
3
[New recommendations for cervical cancer screening in France].[法国宫颈癌筛查的新建议]
Ann Pharm Fr. 2023 Mar;81(2):202-209. doi: 10.1016/j.pharma.2022.09.006. Epub 2022 Sep 21.
4
Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis.评估 COVID-19 大流行对乳腺癌筛查和诊断率的影响:快速综述和荟萃分析。
J Med Screen. 2022 Dec;29(4):209-218. doi: 10.1177/09691413221101807. Epub 2022 May 20.
5
Mobile Mammography Services and Underserved Women.流动乳腺摄影服务与服务不足的女性
Diagnostics (Basel). 2022 Apr 5;12(4):902. doi: 10.3390/diagnostics12040902.
6
Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis.与乳腺癌筛查就诊相关的因素:系统评价和荟萃分析。
BMJ Open. 2021 Nov 30;11(11):e046660. doi: 10.1136/bmjopen-2020-046660.
7
Socio-Territorial Inequities in the French National Breast Cancer Screening Programme-A Cross-Sectional Multilevel Study.法国国家乳腺癌筛查计划中的社会地域不平等——一项横断面多层次研究
Cancers (Basel). 2021 Aug 30;13(17):4374. doi: 10.3390/cancers13174374.
8
Contextual factors associated with cancer screening uptake: A systematic review of observational studies.与癌症筛查参与相关的情境因素:观察性研究的系统评价。
Prev Med. 2021 Sep;150:106692. doi: 10.1016/j.ypmed.2021.106692. Epub 2021 Jun 21.
9
Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study.连续筛查乳腺 X 光检查对乳腺癌死亡率的有益影响:一项前瞻性研究。
Radiology. 2021 Jun;299(3):541-547. doi: 10.1148/radiol.2021203935. Epub 2021 Mar 2.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.